Abstract Number: 1249 • 2017 ACR/ARHP Annual Meeting
What Factors Predict Good Patient Experiences of Switching from Reference Etanercept (EnbrelTM) to an Etanercept Biosimilar (BenepaliTM) in a South West London General Hospital?
Background/Purpose: The introduction of biological (BG) drugs in the last 20 years has revolutionised the treatment of patients with inflammatory arthritis (IA). The development of…
ACR Meeting Abstracts